Skip to main content
Log in

Epithalon Decelerates Aging and Suppresses Development of Breast Adenocarcinomas in Transgenic HER-2/neu Mice

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Female transgenic FVB/N mice carrying the breast cancer gene HER-2/neu received epithalon (Ala-Glu-Asp-Gly) in a dose of 1 mg subcutaneously 5 times a week to from the 2nd month of life to death. Epithalon prolonged the average and maximum lifetimes of mice by 13.5 (p<0.05) and 13.9%, respectively. The peptide prolonged the average lifetime of animals without neoplasms (by 34.2%, p<0.05). Epithalon decelerated the development of age-related disturbances in reproductive activity and suppressed the formation of neoplasms. The peptide decreased the incidence of breast adenocarcinomas, lungs metastases (by 1.6 times, p<0.05), and multiple tumors (by 2 times). Epithalon 3.7-fold increased the number of mice without breast tumors (p<0.05), while the number of animals with 6 or more breast tumors decreased by 3 times (p<0.05). Epithalon prolonged the lifetime of mice with breast tumors by 1.4 times (p<0.05). These results indicate that Epithalon possesses geroprotective activity and inhibits breast carcinogenesis in transgenic mice, which is probably related to suppression of HER-2/neu expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. V. N. Anisimov, V. Kh. Khavinson, I. N. Alimova, et al., Byull. Eksp. Biol. Med., 133,No. 2, 199–203 (2002).

    Google Scholar 

  2. V. Kh. Khavinson, V. V. Yuzhakov, I. M. Kvetnoi, and V. V. Malinin, Vopr. Onkol., 47, 461–466 (2001).

    Google Scholar 

  3. E. R. Andrechek, W. R. Hardy, P. M. Siegel, et al., Proc. Natl. Acad. Sci. USA, 97, 3444–3449 (2000).

    Google Scholar 

  4. V. N. Anisimov, Comprehensive Geriatric Oncology, Eds. L. Balducchi et al., pp. 157–178 (1998).

  5. V. N. Anisimov, Mech. Ageing Dev., 122, 1221–1255 (2001).

    Google Scholar 

  6. V. N. Anisimov, V. Kh. Khavinson, A. I. Mikhalski, and A. I. Yashin, Ibid., 122, 41–68 (2001).

    Google Scholar 

  7. V. N. Anisimov, V. Kh. Khavinson, and V. G. Morozov, Ann. N. Y. Acad. Sci., 719, 483–493 (1994).

    Google Scholar 

  8. R. A. DePinho, Nature, 408, 248–254 (2000).

    Google Scholar 

  9. S. M. Jazwinski, Exp. Gerontol., 34, 1–6 (1999).

    Google Scholar 

  10. V. Kh. Khavinson, D. M. Izmailov, L. K. Obukhova, and V. V. Malinin, Mech. Ageing Dev., 120, 141–149 (2000).

    Google Scholar 

  11. V. Kh. Khavinson, V. G. Morozov, and V. N. Anisimov, The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy, Eds. C. Bartsch et al., Berlin (2001), pp. 294–306.

  12. D. M. Parkin, F. I. Bray, and S. S. Devesa, Eur. J. Cancer, 37, S4–S66 (2001).

    Google Scholar 

  13. E. Stocklin, F. Botteri, and B. Groner, J. Cell Biol., 122, 199–208 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anisimov, V.N., Khavinson, V.K., Alimova, I.N. et al. Epithalon Decelerates Aging and Suppresses Development of Breast Adenocarcinomas in Transgenic HER-2/neu Mice. Bulletin of Experimental Biology and Medicine 134, 187–190 (2002). https://doi.org/10.1023/A:1021104819170

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021104819170

Navigation